Lipsky, A. H., Lozier, J. N. and Wiestner, A. (2016) “Response to Comment on Incidence and Risk Factors of Bleeding-Related Adverse Events in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib”, Haematologica. Pavia, Italy, 101(3), pp. e124-e125. doi: 10.3324/haematol.2015.140558.